BCDA
BCDA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$1K
Insider Sales
0
$0
Total Volume
$1K
45 transactions
Net Activity
+$1K
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$401.97B total
Altman Peter
Pres, CEO
$1K total
Quick Actions
BCDA has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at BCDA (BCDA) engaged in a total of 45 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $1K.
The net insider activity for BCDA shows a net buying bias of $1K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 714.3K shares valued at $284.57B on Sep 19, 2025.
BioCardia, Inc. (BCDA) Stock Price, News, Quote & History
BioCardia, Inc. (BCDA) stock price, news, quote and history
BioCardia, Inc. (BCDA) stock price, news, quote and history
BCDA - BioCardia Inc Stock Price and Quote
Should I buy BioCardia (BCDA)
A $2.2 million cash balance is expected to carry BioCardia into 2027.
FAQs About BCDA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for BCDA.